More Caremark Merger News

Caremark and CVS responded to Express Script’s competing bid for Caremark with measured press releases describing their agreement as “definitive” and stating that Caremark’s board of directors will take the ESI proposal under advisement. The stock market responded by boosting Caremark’s common stock price from $50.30 per share to $55.28 per share as investors expect a bidding war over Caremark.